Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genmab A/S Dkk (OP: GNMSF )

348.24 USD -6.47 (-1.82%)
Official Closing Price Updated: 3:55 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 353.02
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 354.71
Today's Range 348.02 - 356.96
52wk Range 159.45 - 391.76
Shares Outstanding 61,460,843
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Genmab 2017 Annual Report
From GlobeNewswire News Releases
Genmab Announces 2017 Net Sales Figures for DARZALEX® (Daratumumab)
From GlobeNewswire News Releases

Performance

YTD
+62.50%
+62.50%
1 Month
-2.06%
-2.06%
3 Month
-1.76%
-1.76%
6 Month
+44.68%
+44.68%
1 Year
+65.83%
+65.83%

More News

Read More
Genmab Announces Novartis’ Intention to Transition Arzerra® (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets
From GlobeNewswire News Releases
U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma
From GlobeNewswire News Releases
Major Shareholder Announcement
From GlobeNewswire News Releases
Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance
From GlobeNewswire News Releases
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma
From GlobeNewswire News Releases
Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma
From GlobeNewswire News Releases
Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
From GlobeNewswire News Releases
Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance
From GlobeNewswire News Releases
Major Shareholder Announcement
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.